NEW YORK (AP) — A federal advisory panel on Wednesday recommended a new vaccine against hepatitis B.

The vaccine, called Heplisav-B, was licensed for use in the U.S. in November and is the first new hepatitis B vaccine in 25 years.

Hepatitis B vaccines have been in childhood shots for decades. But vaccination also is recommended for adults at high risk of infection, including people who inject drugs, health care workers and jail inmates.

The new vaccine made by Dynavax Technologies Corp. is for adults and uses an additive that boosts the body's immune response. It is given in two shots ov...